Vivos Therapeutics Inc (VVOS)

History and Background

Vivos Therapeutics, Inc. was founded in 2016. It is focused on developing and commercializing innovative treatments for sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA). The company's core technology is the Vivos System, a non-surgical, non-pharmaceutical treatment approach.

Core Business Areas

• Medical Devices: Designs, develops, manufactures, and markets the Vivos System, a suite of oral appliances used in the Vivos Method.
• Educational Services: Provides training and educational programs for dentists and other healthcare professionals on the Vivos Method for treating sleep-disordered breathing.
• Clinical Support: Offers clinical support and guidance to dentists and patients using the Vivos System.

Leadership and Structure

Kirk Huntsman is the CEO and Chairman. The company operates with a functional organizational structure, encompassing R&D, manufacturing, sales, marketing, and clinical support teams.

Key Offerings

• Vivos System: The Vivos System is a multi-disciplinary treatment protocol that utilizes proprietary oral appliances and clinical protocols to address underlying craniofacial deficiencies often associated with sleep apnea and other sleep-disordered breathing conditions. Market share data is difficult to pinpoint exactly due to the fragmented nature of the sleep apnea device market. Competitors include companies making CPAP machines (ResMed, Philips Respironics) and other oral appliances (e.g., those from SomnoMed, Oventus Medical).
• DNA Appliance: This is part of the Vivos System, specifically designed to promote bone growth and development in the upper jaw. Market share data is not specifically available. Competitors are other orthodontic appliances.
• mmRNA Appliance: Another appliance that is part of the system. Revenue from this specific device is not known. Competitors are other orthodontic appliances.

Industry Overview

The sleep apnea and sleep-disordered breathing market is large and growing, driven by increasing awareness, rising obesity rates, and an aging population. The market is competitive, with various treatment options available, including CPAP, oral appliances, and surgery.

Positioning

Vivos Therapeutics positions itself as an alternative to traditional sleep apnea treatments like CPAP, focusing on addressing the underlying anatomical issues contributing to the condition. It is trying to disrupt the market with a non-surgical, non-pharmaceutical approach.

Total Addressable Market (TAM)

The global sleep apnea devices market is estimated at tens of billions of USD and is expected to continue to grow. Vivos is positioned to capture a share of this market by offering a unique treatment approach that targets the root cause of the condition.

Key Competitors

• RMD
• PHG
• ALGN

Competitive Landscape

Vivos competes with established players in the sleep apnea market, such as ResMed and Philips, which offer CPAP and other traditional treatments. It differentiates itself with its non-surgical, non-pharmaceutical approach that addresses the underlying anatomical issues contributing to sleep apnea. Vivos faces challenges in gaining market share due to the established market presence of its competitors, limited clinical data compared to CPAP, and the need for specialized training for dentists.

Historical Growth: Historical growth can be determined with analysis of previous financial reports.

Future Projections: Future projections can be found through analyst reports. Since it is a growing company with growth projections, it is best to consult the most recent analyst reports.

Recent Initiatives: Recent strategic initiatives should be discussed in their quarterly or annual reports. Typically, initiatives are focused on gaining partnerships and additional marketing efforts.

Vivos Therapeutics operates in a large and growing market, offering a unique solution to a widespread problem. However, the company faces strong competition and needs to demonstrate the long-term efficacy of its treatment. Their strategy of addressing root anatomical issues differentiates them from established treatments. Overcoming the adoption challenges of dentists and securing favorable reimbursement policies are key for future success and growth. Current competition makes for a competitive market.

Data Sources:

• Company Website
• SEC Filings
• Analyst Reports
• Industry Publications

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Market share data is based on estimates and may vary. Investment decisions should be based on your own due diligence and consultation with a qualified financial advisor.